Theranostics : Impact Factor & More
eISSN: 1838-7640pISSN: 1838-7640
Open AccessShare this on:
Key Metrics
CiteScore 
16.7
Impact Factor
10 - 15
Scite Index
0.93 5-Year SI
SJR
Q1Medicine (miscellaneous)
SNIP
1.75
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Theranostics
Theranostics Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | IVYSPRING INT PUBL |
| Language | English |
| Frequency | Irregular |
| Article Processing Charges | AUD 2500 |
| Publication Time | 12 |
| Editorial Review Process | Peer review |
| General Details | |
| Language | English |
| Frequency | Irregular |
| Publication Start Year | 2011 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors |
View less
Planning to publish in Theranostics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Theranostics
A tumor-targeted heptamethine cyanine dye suppresses triple-negative breast cancer by induction of lethal autophagy.
- 23 Apr 2026
- Theranostics
Esterase-responsive albumin-binding PROTAC-mediated BRD4 degradation for cancer immunotherapy.
- 23 Apr 2026
- Theranostics
Scalable differentiation of human cardiac organoids from iPSCs generates cardiac tissues for cardiac cell therapy
- 23 Apr 2026
- Theranostics
Quantitative assessment of extravasation of IL-15-secreting MSLN-CAR-NK-92 cells using tumor transparency imaging.
- 23 Apr 2026
- Theranostics
Current trends regarding types, properties, self-healing mechanisms, and therapeutic strategies for diabetic wounds addressed with polysaccharide-based self-repairing hydrogels: a review
- 23 Apr 2026
- Theranostics
Simultaneous inhibition of ID1 and ID3 mitigates fibroblast activation via cell cycle and MEK/ERK pathways in pulmonary fibrosis.
- 16 Apr 2026
- Theranostics
A tumor-targeted heptamethine cyanine dye suppresses triple-negative breast cancer by induction of lethal autophagy.
- 23 Apr 2026
- Theranostics
Esterase-responsive albumin-binding PROTAC-mediated BRD4 degradation for cancer immunotherapy.
- 23 Apr 2026
- Theranostics
Scalable differentiation of human cardiac organoids from iPSCs generates cardiac tissues for cardiac cell therapy
- 23 Apr 2026
- Theranostics
Quantitative assessment of extravasation of IL-15-secreting MSLN-CAR-NK-92 cells using tumor transparency imaging.
- 23 Apr 2026
- Theranostics
Current trends regarding types, properties, self-healing mechanisms, and therapeutic strategies for diabetic wounds addressed with polysaccharide-based self-repairing hydrogels: a review
- 23 Apr 2026
- Theranostics
Simultaneous inhibition of ID1 and ID3 mitigates fibroblast activation via cell cycle and MEK/ERK pathways in pulmonary fibrosis.
- 16 Apr 2026
- Theranostics
FAQs on Theranostics
How long has Theranostics been actively publishing? 
What is the publishing frequency of Theranostics?
How many articles did Theranostics publish last year?
What is the eISSN & pISSN for Theranostics?
What is Citescore for Theranostics?
What is SNIP score for Theranostics?
What is the SJR for Theranostics?
Who is the publisher of Theranostics?
